News - BRL Medicine Inc.

Nature Medicine article states that BRL-101 gene therapy for thalassemia has cured children for over 2 years

2022-08-04

2022 Future Healthcare VB100｜BRL Medicine awarded as

2022-06-16

BRL Medicine Inc. formally appointed Dr. Biao Zheng as CEO

2022-05-20

Change of Entity English Name Letter of Notification

2022-01-07

BRL Medicine passed the acceptance and was awarded "Shanghai Patent Work Pilot Excellent Unit"!

2021-12-03

BRL Medicine and CTO Institute of ECNU Signed a Strategic Cooperation between School and Enterprise

On the morning of November 5, 2021,the opening ceremony for the “Biomedical Industry CTO Executive Education and Innovation Strategy Demonstration Base” and Seminar on the Cultivation of Leader Talents in Cell and Gene Therapy Technology hosted by Shanghai International School of Chief Technology Officer (hereinafter referred to as “CTO School”) of East China Normal University, Shanghai BRL Medicine Co., Ltd. (hereinafter referred to as “BRL Medicine”), the Asia Europe Business School of East China Normal University and East China Normal University-University of Haifa Joint Translational Science and Technology Research Institute (hereinafter referred to as “Joint Research Institute”) was successfully held in Building A2, Zizhu International Education Park, Minhang District, Shanghai.

2021-11-06

Company News